Contents:
Document Title
Guideline for deactivation of cardioverter defibrillators towards the end of life
Document Date
December 2022
Document Purpose and Intended Audience
A guideline to support local organisations to establish logistical resources to support the use of the national guidance on ICD deactivation.
Authors
Dr Jon Tomas, Palliative Medicine Consultant, University Hospital Coventry and Warwickshire
Dr Sophie Taylor, Palliative Medicine Registrar, West Midlands
Dr Emma Wooldridge, Palliative Medicine Registrar, West Midlands
Consultation Process
Reviewed by SPAGG and ratified
Monitoring
This will be audited and reviewed every 3 years
Review Date
(must be within three years)
December 2025
Approval Signatures:
SPAGG chair
Dr Jon Tomas
SPAGG secretary
Dr Alice Gray
Date Approved by SPAGG: December 2022
Date submitted to Area Prescribing Committee: N/A
Version History
Version n/a
Date
N/A
Summary of change/ process
N/A
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.